Latest

BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market

CEO Roadshow - October 20, 2018

BioSig (BSGM) Continues to Advance with FDA 510(K) Clearance and NASDAQ Uplisting on the Horizon

CEO Roadshow - August 29, 2018

BioSig $BSGM Shows Promise for Investors in One of the Fastest Growing Medical Device Segments

CEO Roadshow - November 8, 2017

BioSig Videos

Home BioSig Technologies BioSig Videos

BioSig Videos

BioSig’s $BSGM Disruptive Technology Nears Commercialization in $4B EP Market

CEO Roadshow - October 26, 2017

- Advertisement -

LATEST NEWS

Charge Enterprises (OTC PINK: CRGE) Enters into Definitive Agreement to Acquire ANS Advanced Network...

CEO Roadshow - May 13, 2021

AIM ImmunoTech (NYSEMKT: AIM) CEO Participates in Fireside Chat with Ascendiant Capital Markets Analyst...

CEO Roadshow - May 7, 2021

U.S. Gold Corp. Announces Plans for 2021 Summer Field Season Program at the CK...

CEO Roadshow - May 4, 2021

CEORoadshow 2021 Webinar Series Presents Genprex, Inc. (NASDAQ: GNPX)

CEO Roadshow - April 19, 2021

LATEST INTERVIEWS

CEORoadshow’s Top Gold Stocks Interviews Luke Norman, Co-Founder of U.S. Gold...

CEO Roadshow - May 3, 2021

CEORoadshow Interviews

In this episode of CEO Roadshow, we are joined by Mr. Luke Norman, Co-Founder of U.S. Gold Corp., a gold exploration and development company. Luke...

CEORoadshow Interview with Rodney Varner, CEO of Genprex, Inc. (NASDAQ: GNPX)

CEO Roadshow - April 27, 2021

CEORoadshow Interviews

In this episode of CEO Roadshow, we are joined by Rodney Varner, President, and CEO of Genprex. Genprex is a clinical-stage gene therapy company...